In the quantification of symptoms of Parkinson’s disease (PD), healthcare professional assessments, patient reported outcomes (PRO), and medical device grade wearables are currently used. Recently, al
Comparison of sub-items on the MDS-UPDRS parts I and II between patients with PD with and without pRBD as evaluated by the Japanese version of the RBD screening questionnaire.
